Balance Sheet S&P Global, Inc.

Equities

SPGI

US78409V1044

Professional Information Services

Market Closed - Nyse Other stock markets 04:00:02 2025-12-10 pm EST			Pre-market 07:37:56 pm
491.32 ^USD	+0.12%		488.14	-0.65%

07:27pm	Kellanova(NYSE:K) dropped from S&P Global BMI Index	CI
07:24pm	Akero Therapeutics, Inc.(NasdaqGS:AKRO) dropped from S&P Global BMI Index	CI

8d61b80d2e191a4778a257cd57a6b850.v_BbzXGYDXjH4hUV0pNUSck5n0EEuy_RImiWuPruWVY.2qU1iyP7fxKF239P5tQhBa8N3CttynjpEBHP3pabAGbamhH5GsxYG52NTA

Published financial data: S&P GLOBAL, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	7.44B	8.3B	11.18B	12.5B	14.21B
Total Revenues	7.44B	8.3B	11.18B	12.5B	14.21B
Cost of Goods Sold, Total	2.09B	2.2B	3.77B	4.14B	4.39B
Gross Profit	5.35B	6.1B	7.42B	8.36B	9.82B
Selling General & Admin Expenses, Total	1.27B	1.39B	2.44B	2.64B	2.85B
Depreciation & Amortization - (IS)	83M	82M	108M	101M	96M
Amortization of Goodwill and Intangible Assets - (IS)	123M	96M	905M	1.04B	1.08B
Other Operating Expenses, Total	1.48B	1.57B	3.45B	3.78B	4.02B
Operating Income	3.87B	4.54B	3.96B	4.57B	5.79B
Interest Expense, Total	-141M	-119M	-300M	-330M	-293M
Net Interest Expenses	-141M	-119M	-300M	-330M	-293M
Income (Loss) On Equity Invest.	-	-	27M	36M	43M
Currency Exchange Gains (Loss)	-	-	-4M	-4M	-4M
EBT, Excl. Unusual Items	3.73B	4.42B	3.69B	4.28B	5.54B
Restructuring Charges	-66M	-19M	-288M	-183M	-127M
Merger & Related Restructuring Charges	-36M	-255M	-615M	-315M	-133M
Gain (Loss) On Sale Of Investments	-1M	17M	59M	-15M	1M
Gain (Loss) On Sale Of Assets	16M	11M	1.9B	-70M	59M
Asset Writedown	-133M	-3M	-18M	-21M	-3M
Insurance Settlements	-	-	-	-	-
Legal Settlements	-	-	-	-	-20M
Other Unusual Items	-281M	-3M	-21M	-	-9M
EBT, Incl. Unusual Items	3.23B	4.16B	4.7B	3.67B	5.31B
Income Tax Expense	694M	901M	1.18B	778M	1.14B
Earnings From Continuing Operations	2.53B	3.26B	3.52B	2.89B	4.17B
Net Income to Company	2.53B	3.26B	3.52B	2.89B	4.17B
Minority Interest	-195M	-239M	-274M	-267M	-315M
Net Income - (IS)	2.34B	3.02B	3.25B	2.63B	3.85B
Net Income to Common Incl Extra Items	2.34B	3.02B	3.25B	2.63B	3.85B
Net Income to Common Excl. Extra Items	2.34B	3.02B	3.25B	2.63B	3.85B
Per Share Items
Net EPS - Basic	9.71	12.56	10.25	8.25	12.36
Basic EPS - Continuing Operations	9.71	12.56	10.25	8.25	12.36
Basic Weighted Average Shares Outstanding	241M	241M	317M	318M	312M
Net EPS - Diluted	9.66	12.51	10.2	8.23	12.35
Diluted EPS - Continuing Operations	9.66	12.51	10.2	8.23	12.35
Diluted Weighted Average Shares Outstanding	242M	242M	318M	319M	312M
Normalized Basic EPS	8.86	10.47	6.41	7.55	10.1
Normalized Diluted EPS	8.82	10.43	6.37	7.54	10.09
Dividend Per Share	2.68	3.08	3.32	3.6	3.64
Payout Ratio	27.58	24.57	31.53	43.68	29.44
American Depositary Receipts Ratio (ADR)	0.03	0.03	0.03	0.03	0.03
Supplemental Items
EBITDA	4.08B	4.71B	4.98B	5.72B	6.97B
EBITA	3.99B	4.63B	4.87B	5.62B	6.87B
EBIT	3.87B	4.54B	3.96B	4.57B	5.79B
EBITDAR	4.21B	4.84B	5.12B	5.83B	7.08B
Effective Tax Rate - (Ratio)	21.5	21.64	25.1	21.19	21.5
Current Domestic Taxes	460M	591M	1.19B	775M	992M
Current Foreign Taxes	246M	295M	322M	370M	472M
Total Current Taxes	706M	886M	1.52B	1.14B	1.46B
Deferred Domestic Taxes	-3M	-8M	-237M	-217M	-162M
Deferred Foreign Taxes	-9M	23M	-98M	-150M	-161M
Total Deferred Taxes	-12M	15M	-335M	-367M	-323M
Normalized Net Income	2.14B	2.52B	2.03B	2.4B	3.15B
Non-Cash Pension Expense	-30M	-40M	-11M	2M	-20M
Supplemental Operating Expense Items
Advertising Expense	29M	39M	177M	209M	229M
Research And Development Expense From Footnotes	13M	-	-	-	-
Net Rental Expense, Total	138M	122M	147M	118M	116M
Imputed Operating Lease Interest Expense	33M	23.88M	42.45M	26.23M	22.52M
Imputed Operating Lease Depreciation	105M	98.12M	105M	91.77M	93.48M
Stock-Based Comp., Other (Total)	90M	122M	214M	171M	247M
Total Stock-Based Compensation	90M	122M	214M	171M	247M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	4.11B	6.5B	1.29B	1.29B	1.67B
Short Term Investments	9M	11M	14M	26M	20M
Total Cash And Short Term Investments	4.12B	6.51B	1.3B	1.32B	1.69B
Accounts Receivable, Total	1.59B	1.65B	2.49B	2.83B	2.87B
Total Receivables	1.59B	1.65B	2.49B	2.83B	2.87B
Prepaid Expenses	241M	311M	566M	922M	902M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	14M	8M	1M	1M	-
Other Current Assets, Total	23M	333M	1.31B	78M	4M
Total Current Assets	5.99B	8.81B	5.67B	5.14B	5.46B
Gross Property Plant And Equipment	1.36B	1.29B	1.58B	1.43B	1.5B
Accumulated Depreciation	-587M	-620M	-859M	-794M	-823M
Net Property Plant And Equipment	778M	667M	720M	637M	678M
Long-term Investments	-	-	1.9B	1.92B	1.77B
Goodwill	3.74B	3.51B	34.54B	34.85B	34.92B
Other Intangibles, Total	1.41B	1.33B	18.38B	17.51B	16.69B
Deferred Tax Assets Long-Term	67M	56M	81M	64M	73M
Other Long-Term Assets, Total	558M	659M	499M	467M	630M
Total Assets	12.54B	15.03B	61.78B	60.59B	60.22B
Liabilities
Accounts Payable, Total	233M	205M	450M	557M	553M
Accrued Expenses, Total	551M	607M	753M	906M	1.07B
Short-term Borrowings	-	-	226M	-	-
Current Portion of Long-Term Debt	-	-	-	47M	4M
Current Portion of Leases	100M	96M	118M	105M	109M
Current Income Taxes Payable	84M	90M	116M	121M	199M
Unearned Revenue Current, Total	2.17B	2.22B	3.13B	3.46B	3.69B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	451M	600M	1.21B	928M	760M
Total Current Liabilities	3.59B	3.82B	6B	6.12B	6.39B
Long-Term Debt	4.11B	4.38B	10.73B	11.41B	11.39B
Long-Term Leases	544M	492M	577M	541M	535M
Pension & Other Post Retirement Benefits	291M	262M	180M	199M	180M
Deferred Tax Liability Non Current	177M	147M	4.06B	3.69B	3.4B
Other Non Current Liabilities	476M	390M	489M	522M	815M
Total Liabilities	9.18B	9.49B	22.04B	22.49B	22.71B
Common Stock, Total	294M	294M	415M	415M	415M
Additional Paid In Capital	946M	1.03B	44.42B	44.23B	44.32B
Retained Earnings	13.37B	15.02B	17.78B	18.73B	20.98B
Treasury Stock	-13.46B	-13.47B	-25.35B	-28.41B	-31.67B
Comprehensive Income and Other	-637M	-841M	-886M	-763M	-883M
Total Common Equity	509M	2.03B	36.39B	34.2B	33.16B
Minority Interest	2.84B	3.5B	3.36B	3.9B	4.35B
Total Equity	3.35B	5.54B	39.74B	38.1B	37.51B
Total Liabilities And Equity	12.54B	15.03B	61.78B	60.59B	60.22B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	241M	241M	322M	314M	308M
ECS Total Common Shares Outstanding	241M	241M	322M	314M	308M
Book Value / Share	2.12	8.43	113.04	108.88	107.73
Tangible Book Value	-4.64B	-2.8B	-16.53B	-18.16B	-18.45B
Tangible Book Value Per Share	-19.27	-11.63	-51.36	-57.81	-59.94
Total Debt	4.75B	4.97B	11.65B	12.1B	12.04B
Net Debt	637M	-1.54B	10.35B	10.79B	10.36B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-23M	-109M	-57M	-48M	-72M
Debt Equivalent Oper. Leases	1.1B	976M	1.18B	944M	928M
Minority Interest, Total (Incl. Fin. Div)	2.84B	3.5B	3.36B	3.9B	4.35B
Equity Method Investments, Total	-	-	1.75B	1.79B	1.77B
Account Code - Inventory Valuation	3	3	3	-	3
Buildings, Total	364M	346M	468M	424M	433M
Machinery, Total	507M	515M	688M	628M	655M
Full Time Employees	23K	22.85K	39.95K	40.45K	42.35K
Accumulated Allowance for Doubtful Accounts (Supple)	30M	26M	48M	54M	44M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	2.34B	3.02B	3.25B	2.63B	3.85B
Depreciation & Amortization - CF	83M	82M	108M	101M	96M
Amortization of Goodwill and Intangible Assets - (CF)	123M	96M	905M	1.04B	1.08B
Depreciation & Amortization, Total	206M	178M	1.01B	1.14B	1.17B
(Gain) Loss From Sale Of Asset	-16M	-11M	-1.9B	70M	-59M
Asset Writedown & Restructuring Costs	120M	31M	132M	246M	206M
Stock-Based Compensation (CF)	90M	122M	214M	171M	247M
Provision and Write-off of Bad Debts	17M	14M	24M	28M	43M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	564M	310M	-56M	-114M	-8M
Change In Accounts Receivable	18M	-144M	36M	-291M	-79M
Change In Accounts Payable	132M	38M	43M	328M	245M
Change in Unearned Revenues	220M	198M	37M	352M	222M
Change In Income Taxes	-2M	-36M	-135M	-175M	192M
Change in Other Net Operating Assets	-121M	-126M	-55M	-674M	-345M
Cash from Operations	3.57B	3.6B	2.6B	3.71B	5.69B
Capital Expenditure	-76M	-35M	-89M	-143M	-124M
Cash Acquisitions	-201M	-99M	210M	-296M	-305M
Divestitures	18M	16M	3.51B	1.01B	168M
Investment in Marketable and Equity Securities, Total	19M	-2M	-2M	-13M	6M
Cash from Investing	-240M	-120M	3.63B	562M	-255M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	1.28B	-	5.4B	744M	-
Total Debt Issued	1.28B	-	5.4B	744M	-
Short Term Debt Repaid, Total	-	-	-32M	-188M	-
Long-Term Debt Repaid, Total	-1.39B	-	-3.7B	-	-47M
Total Debt Repaid	-1.39B	-	-3.73B	-188M	-47M
Issuance of Common Stock	16M	13M	7M	13M	-
Repurchase of Common Stock	-1.22B	-56M	-12.11B	-3.41B	-3.42B
Common Dividends Paid	-645M	-743M	-1.02B	-1.15B	-1.13B
Common & Preferred Stock Dividends Paid	-645M	-743M	-1.02B	-1.15B	-1.13B
Other Financing Activities, Total	-194M	-227M	140M	-289M	-394M
Cash from Financing	-2.17B	-1.01B	-11.33B	-4.28B	-5B
Foreign Exchange Rate Adjustments	75M	-82M	-123M	12M	-61M
Net Change in Cash	1.24B	2.38B	-5.22B	4M	375M
Supplemental Items
Cash Interest Paid	159M	130M	240M	369M	391M
Cash Income Tax Paid (Refund)	683M	883M	1.56B	1.28B	1.16B
Levered Free Cash Flow	3B	2.83B	3.3B	4.68B	5.09B
Unlevered Free Cash Flow	3.09B	2.9B	3.49B	4.89B	5.28B
Change In Net Working Capital	-453M	199M	129M	-858M	-360M
Net Debt Issued / Repaid	-118M	-	1.66B	556M	-47M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	20.25	20.57	6.45	4.67	5.99
Return on Total Capital	31.03	30.45	8	5.63	7.26
Return On Equity %	82.33	73.42	15.56	7.43	11.02
Return on Common Equity	473.48	238.02	16.91	7.44	11.44
Margin Analysis
Gross Profit Margin %	71.89	73.54	66.32	66.86	69.09
SG&A Margin	17.12	16.74	21.8	21.12	20.06
EBITDA Margin %	54.77	56.8	44.51	45.74	49.04
EBITA Margin %	53.65	55.82	43.55	44.93	48.36
EBIT Margin %	52	54.66	35.45	36.59	40.78
Income From Continuing Operations Margin %	34.05	39.33	31.5	23.15	29.33
Net Income Margin %	31.43	36.45	29.05	21.01	27.11
Net Avail. For Common Margin %	31.43	36.45	29.05	21.01	27.11
Normalized Net Income Margin	28.7	30.38	18.16	19.24	22.15
Levered Free Cash Flow Margin	40.36	34.06	29.51	37.46	35.85
Unlevered Free Cash Flow Margin	41.54	34.96	31.18	39.11	37.14
Asset Turnover
Asset Turnover	0.62	0.6	0.29	0.2	0.24
Fixed Assets Turnover	8.39	11.48	16.12	18.42	21.61
Receivables Turnover (Average Receivables)	4.7	5.12	5.4	4.7	4.99
Short Term Liquidity
Current Ratio	1.67	2.31	0.94	0.84	0.85
Quick Ratio	1.59	2.14	0.63	0.68	0.71
Operating Cash Flow to Current Liabilities	0.99	0.94	0.43	0.61	0.89
Days Sales Outstanding (Average Receivables)	77.95	71.33	67.64	77.69	73.33
Average Days Payable Outstanding	37	36.42	31.74	44.38	46.26
Long Term Solvency
Total Debt/Equity	141.83	89.81	29.32	31.77	32.11
Total Debt / Total Capital	58.65	47.32	22.67	24.11	24.3
LT Debt/Equity	138.84	88.08	28.45	31.37	31.8
Long-Term Debt / Total Capital	57.41	46.4	22	23.81	24.07
Total Liabilities / Total Assets	73.26	63.16	35.67	37.12	37.72
EBIT / Interest Expense	27.45	38.11	13.21	13.86	19.77
EBITDA / Interest Expense	29.89	40.63	17.08	17.68	24.17
(EBITDA - Capex) / Interest Expense	29.35	40.34	16.78	17.25	23.75
Total Debt / EBITDA	1.13	1.03	2.27	2.07	1.7
Net Debt / EBITDA	0.15	-0.32	2.02	1.85	1.46
Total Debt / (EBITDA - Capex)	1.15	1.04	2.31	2.13	1.73
Net Debt / (EBITDA - Capex)	0.15	-0.32	2.06	1.9	1.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.09	11.49	34.76	11.77	13.69
Gross Profit, 1 Yr. Growth %	13.28	14.1	21.52	12.49	17.48
EBITDA, 1 Yr. Growth %	17.26	15.63	5.6	15.38	21.89
EBITA, 1 Yr. Growth %	17.65	15.98	5.14	15.87	22.37
EBIT, 1 Yr. Growth %	18.28	17.18	-12.59	16.04	26.7
Earnings From Cont. Operations, 1 Yr. Growth %	10.03	28.77	7.94	-17.86	44.04
Net Income, 1 Yr. Growth %	10.17	29.29	7.41	-19.15	46.69
Normalized Net Income, 1 Yr. Growth %	20.19	18.04	-19.46	19.29	30.88
Diluted EPS Before Extra, 1 Yr. Growth %	12.33	29.5	-18.47	-19.31	50.06
Accounts Receivable, 1 Yr. Growth %	1.01	3.58	51.15	13.31	1.45
Net Property, Plant and Equip., 1 Yr. Growth %	-21.89	-14.27	7.95	-11.53	6.44
Total Assets, 1 Yr. Growth %	10.48	19.85	311.18	-1.93	-0.61
Tangible Book Value, 1 Yr. Growth %	0.74	-39.57	490.01	9.83	1.6
Common Equity, 1 Yr. Growth %	6.26	299.21	1.69K	-6.01	-3.04
Cash From Operations, 1 Yr. Growth %	28.49	0.87	-27.65	42.53	53.34
Capital Expenditures, 1 Yr. Growth %	-33.91	-53.95	154.29	60.67	-13.29
Levered Free Cash Flow, 1 Yr. Growth %	30.09	-5.91	16.61	42.51	8.83
Unlevered Free Cash Flow, 1 Yr. Growth %	28.98	-6.19	20.21	40.75	7.98
Dividend Per Share, 1 Yr. Growth %	17.54	14.93	7.79	8.43	1.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.05	11.29	22.57	22.73	12.73
Gross Profit, 2 Yr. CAGR %	10.02	13.67	17.75	16.88	14.96
EBITDA, 2 Yr. CAGR %	13.45	16.44	10.5	10.16	18.54
EBITA, 2 Yr. CAGR %	13.81	16.81	10.43	10.15	19.03
EBIT, 2 Yr. CAGR %	14.32	17.73	1.21	0.45	21.19
Earnings From Cont. Operations, 2 Yr. CAGR %	9.3	19.03	17.89	-5.84	8.77
Net Income, 2 Yr. CAGR %	9.3	19.35	17.84	-6.81	8.9
Normalized Net Income, 2 Yr. CAGR %	15.39	19.11	-2.5	-2.29	24.87
Diluted EPS Before Extra, 2 Yr. CAGR %	11.79	20.61	2.76	-18.89	10.04
Accounts Receivable, 2 Yr. CAGR %	4.85	2.29	25.12	30.87	7.22
Net Property, Plant and Equip., 2 Yr. CAGR %	69.75	-18.17	-3.8	-2.27	-2.96
Total Assets, 2 Yr. CAGR %	15.24	15.07	121.99	100.81	-1.27
Tangible Book Value, 2 Yr. CAGR %	1.16	-21.98	88.82	154.56	5.64
Common Equity, 2 Yr. CAGR %	-9.97	105.97	745.51	310.25	-4.54
Cash From Operations, 2 Yr. CAGR %	31.46	13.85	-14.57	1.54	47.84
Capital Expenditures, 2 Yr. CAGR %	-17.99	-44.83	8.22	102.13	18.04
Levered Free Cash Flow, 2 Yr. CAGR %	34.84	10.63	4.8	28.67	24.49
Unlevered Free Cash Flow, 2 Yr. CAGR %	33.47	10	6.19	29.85	23.24
Dividend Per Share, 2 Yr. CAGR %	15.76	16.23	11.3	8.11	4.71
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.07	9.86	18.62	18.86	19.64
Gross Profit, 3 Yr. CAGR %	6.99	11.35	16.22	16.04	17.08
EBITDA, 3 Yr. CAGR %	11.62	14.17	12.71	11.93	13.94
EBITA, 3 Yr. CAGR %	11.91	14.52	12.78	12.03	14.08
EBIT, 3 Yr. CAGR %	12.05	15.27	6.6	5.72	8.53
Earnings From Cont. Operations, 3 Yr. CAGR %	15.65	15.44	15.21	4.52	8.49
Net Income, 3 Yr. CAGR %	16.06	15.59	15.23	3.93	8.4
Normalized Net Income, 3 Yr. CAGR %	12.89	16.27	4.55	4.04	7.71
Diluted EPS Before Extra, 3 Yr. CAGR %	18.67	17.41	5.85	-5.2	-0.43
Accounts Receivable, 3 Yr. CAGR %	6.49	4.43	16.51	21.06	20.22
Net Property, Plant and Equip., 3 Yr. CAGR %	41.43	35.18	-10.25	-6.45	0.55
Total Assets, 3 Yr. CAGR %	9.98	16.75	75.92	69.07	58.84
Tangible Book Value, 3 Yr. CAGR %	7.33	-14.8	53.14	57.62	87.42
Common Equity, 3 Yr. CAGR %	-10.46	47.91	323.52	306.54	153.64
Cash From Operations, 3 Yr. CAGR %	20.95	20.35	-2.12	1.32	16.5
Capital Expenditures, 3 Yr. CAGR %	-14.83	-32.34	-8.19	23.45	52.45
Levered Free Cash Flow, 3 Yr. CAGR %	20.37	19.6	12.63	15.94	21.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	19.42	18.67	13.3	16.49	22.11
Dividend Per Share, 3 Yr. CAGR %	17.79	15.48	13.34	10.34	5.73
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.97	7.95	13.02	14.83	16.23
Gross Profit, 5 Yr. CAGR %	8.28	9.43	11.16	13.58	15.76
EBITDA, 5 Yr. CAGR %	13.02	13.79	11.17	12.54	14.92
EBITA, 5 Yr. CAGR %	13.5	14.19	11.31	12.74	15.15
EBIT, 5 Yr. CAGR %	13.52	14.65	7.58	9.08	12.11
Earnings From Cont. Operations, 5 Yr. CAGR %	14.85	7.93	16.55	6.4	12.59
Net Income, 5 Yr. CAGR %	15.14	7.5	16.77	6.05	12.65
Normalized Net Income, 5 Yr. CAGR %	14.04	16.09	6.47	8.44	12.11
Diluted EPS Before Extra, 5 Yr. CAGR %	18.07	9.52	12.03	1.26	7.51
Accounts Receivable, 5 Yr. CAGR %	9.96	8.02	13.59	14.29	12.7
Net Property, Plant and Equip., 5 Yr. CAGR %	23.57	19.74	21.23	18.73	-7.4
Total Assets, 5 Yr. CAGR %	8.91	11.63	45.65	45.04	39.63
Tangible Book Value, 5 Yr. CAGR %	1.68	-6.2	34.54	32	32
Common Equity, 5 Yr. CAGR %	21.28	25.6	119.82	122.44	133.37
Cash From Operations, 5 Yr. CAGR %	73.48	18.19	5.24	12.44	15.43
Capital Expenditures, 5 Yr. CAGR %	-11.37	-21.17	-6.27	4.82	1.52
Levered Free Cash Flow, 5 Yr. CAGR %	74.32	8.92	13.88	23.16	17.15
Unlevered Free Cash Flow, 5 Yr. CAGR %	90.61	8.19	13.94	23	17.1
Dividend Per Share, 5 Yr. CAGR %	15.22	16.42	15.15	12.47	9.81